Floatz logo

N-Butyl Cyanoacrylate

Periampullary Adenocarcinoma

Minia UniversitySmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Periampullary Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Human Fibrinogen
Asan Medical Center
Phase 4BB
Xaliplatin
National Cancer Institute (NCI)
Phase 2B
Fluorouracilum
National Cancer Institute (NCI)
Phase 2CCC
Cis-Diamminedichloroplatinum Ii
New Mexico Cancer Research Alliance
Phase 2CCC
Escitalopram
Case Comprehensive Cancer Center
Phase 2CCC

View all 12 →

Same molecule, other indications

N-Butyl Cyanoacrylate is also rated in:

duodenum cancerActive
B
Indicative · Phase 3
60 / 100
View asset →
bile duct cancerActive
B
Indicative · Phase 3
60 / 100
View asset →
cholangiocarcinomaActive
CCC
Indicative · Phase 3
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →